(Q43143859)

English

Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

scientific article published on 2 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

circulatory system

1 reference

based on heuristic

inferred from title

6

object named as

Winfried März

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2

object named as

Stefan Pilz

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

Andreas Tomaschitz

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Eberhard Ritz

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Andreas Meinitzer

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Bernhard O Boehm

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

2 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1237-1247

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Aldosterone blockade in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Should aldosterone blockade be used beyond current indications in heart failure?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Cardiovascular outcomes in patients with primary aldosteronism after treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Primary aldosteronism: renaissance of a syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Aldosterone production is activated in failing ventricle in humans

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Effects of aldosterone on the vasculature

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Acute effects of aldosterone on intracardiac monophasic action potentials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Rapid effects of aldosterone on clonal human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Rapid actions of aldosterone in vascular health and disease--friend or foe?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Automated Chemiluminescence-Immunoassay for Aldosterone during Dynamic Testing: Comparison to Radioimmunoassays with and without Extraction Steps

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ019

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ019

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43143859&oldid=1981583141"